Jianyu Rao

Professor, Pathology and Laboratory Medicine, University of California Los Angeles

Publications

  1. Lim D, Yu W, Sajed D, Rao J, Rodriguez EF, Moatamed NA. An unusual neck mass diagnosed by fine needle aspiration: Cytological findings and challenges.. CytoJournal, 2024.
  2. Han S, Yao J, Yamazaki H, Streicher SA, Rao J, Nianogo RA, Zhang Z, Huang BZ. Genetically Determined Circulating Lactase/Phlorizin Hydrolase Concentrations and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study.. Nutrients, 2024.
  3. Raghunathan R, Longstaff XR, Hughes EG, Li SJ, Sant VR, Tseng CH, Rao J, Wu JX, Yeh MW, Livhits MJ. Diagnostic performance of molecular testing in indeterminate (Bethesda III and IV) thyroid nodules with Hürthle cell cytology.. Surgery, 2023.
  4. Zhang M, Hashibe M, Rao JY, Jung SY, Tashkin DP, Morgenstern H, Zhang ZF. Opium, phencyclidine, and crack cocaine smoking associations with lung and upper aerodigestive tract cancers: exploratory findings from a case-control study in Los Angeles County.. The American journal of drug and alcohol abuse, 2023.
  5. Huang RR, Giafaglione JM, Hashimoto T, Zhang L, Yu W, Rao J, Russo JW, Balk SP, Nickols NG, Rettig MB, Goldstein A, Ye H. Androgen Drives the Expression of SARS-CoV-2 Entry Proteins in Sinonasal Tissue.. Journal of clinical and translational pathology, 2023.
  6. Kim T, Rao J. "SMART" cytology: The next generation cytology for precision diagnosis.. Seminars in diagnostic pathology, 2023.
  7. Yu W, Sharma S, Rao E, Rowat AC, Gimzewski JK, Han D, Rao J. Cancer cell mechanobiology: a new frontier for cancer research.. Journal of the National Cancer Center, 2021.
  8. Liang Q, Le Q, Wang L, Cordova D, Baclagon E, Garrido SG, Levin M, Jin Y, Tseng CH, Rao J, Deng SX. Cytokeratin 13 Is a New Biomarker for the Diagnosis of Limbal Stem Cell Deficiency.. Cornea, 2021.
  9. Rao J, Lim CT, Hu T, Han D. Editorial: Cancer Cell Mechanobiology - A New Frontier for Cancer Invasion and Metastasis Research.. Frontiers in cell and developmental biology, 2021.
  10. Lau RP, Kim TH, Rao J. Advances in Imaging Modalities, Artificial Intelligence, and Single Cell Biomarker Analysis, and Their Applications in Cytopathology.. Frontiers in medicine, 2021.
  11. Fang F, Mu L, Zhu Y, Rao J, Heymann J, Zhang ZF. Long-Term Exposure to PM2.5, Facemask Mandates, Stay Home Orders and COVID-19 Incidence in the United States.. International journal of environmental research and public health, 2021.
  12. Yu W, Rao E, Chin CD, Aguilar-Jakthong JS, Li Y, Chow C, Wang SYG, Rao J. A Preliminary Study of Deep-Learning Algorithm for Analyzing Multiplex Immunofluorescence Biomarkers in Body Fluid Cytology Specimens.. Acta cytologica, 2021.
  13. Yu R, Yang SE, Rao J. Atypical de Quervain's thyroiditis diagnosed as atypia of undetermined significance by cytology and suspicious for cancer by Afirma Genomic Sequencing Classifier.. Diagnostic cytopathology, 2021.
  14. Livhits MJ, Zhu CY, Kuo EJ, Nguyen DT, Kim J, Tseng CH, Leung AM, Rao J, Levin M, Douek ML, Beckett KR, Cheung DS, Gofnung YA, Smooke-Praw S, Yeh MW. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial.. JAMA oncology, 2021.
  15. Yu W, Lu QY, Sharma S, Ly C, Di Carlo D, Rowat AC, LeClaire M, Kim D, Chow C, Gimzewski JK, Rao J. Single Cell Mechanotype and Associated Molecular Changes in Urothelial Cell Transformation and Progression.. Frontiers in cell and developmental biology, 2020.
  16. Chang CP, Meyers TJ, Fu A, Zhang MY, Tashkin DP, Rao JY, Cozen W, Mack TM, Hashibe M, Morgenstern H, Zhang ZF. Dietary glycemic index, glycemic load, and lung cancer risk: A case-control study in Los Angeles County.. Cancer epidemiology, 2020.
  17. Zhu CY, Sha SW, Tseng CH, Yang SE, Orr LE, Levin M, Wong CW, Livhits MJ, Rao J, Yeh MW. Trends in the Surgical Management of Known or Suspected Differentiated Thyroid Cancer at a Single Institution, 2010-2018.. Thyroid : official journal of the American Thyroid Association, 2020.
  18. Rao J. Computational Technology with Artificial Intelligence and Machine Learning: What Should a Cytologist Do with It?. Acta cytologica, 2020.
  19. Nguyen L, Chopra S, Laskar DB, Rao J, Lieu D, Chung F, Kim ED, de Peralta-Venturina M, Bose S, Balzer B. NOR-1 distinguishes acinic cell carcinoma from its mimics on fine-needle aspiration biopsy specimens.. Human pathology, 2020.
  20. Chin CD, Fares CM, Campos M, Chen HW, Shintaku IP, Konecny GE, Rao J. Association of PD-L1 expression by immunohistochemistry and gene microarray with molecular subtypes of ovarian tumors.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020.
  21. Yu WB, Rao JY. Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma.. Chronic diseases and translational medicine, 2019.
  22. Prendergast EN, Holman LL, Liu AY, Lai TS, Campos MP, Fahey JN, Wang X, Abdelaal N, Rao JY, Elvin JA, Moore KM, Konecny GE, Cohen JG. Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy.. Gynecologic oncology, 2019.
  23. Sharma S, Aguilera R, Rao J, Gimzewski JK. Piezoelectric needle sensor reveals mechanical heterogeneity in human thyroid tissue lesions.. Scientific reports, 2019.
  24. Livhits MJ, Kuo EJ, Leung AM, Rao J, Levin M, Douek ML, Beckett KR, Zanocco KA, Cheung DS, Gofnung YA, Smooke-Praw S, Yeh MW. Gene Expression Classifier vs Targeted Next-Generation Sequencing in the Management of Indeterminate Thyroid Nodules.. The Journal of clinical endocrinology and metabolism, 2018.
  25. Caron JE, Ying Y, Ye Q, Cheng L, Rao JY. International telecytology: Current applications and future potential.. Diagnostic cytopathology, 2018.
  26. Shim J, Rao J, Yu R. Spontaneous Regression of Metastatic Papillary Thyroid Cancer in a Lymph Node.. Case reports in endocrinology, 2018.
  27. Yu SP, Lee BB, Han MN, Chan C, Rao J, Levin M, Fung PC, Parker W. Irrigation after Laparoscopic Power Morcellation and the Dispersal of Leiomyoma Cells: A Pilot Study.. Journal of minimally invasive gynecology, 2018.
  28. Yu WB, Rao A, Vu V, Xu L, Rao JY, Wu JX. Management of centrally located hepatocellular carcinoma: Update 2016.. World journal of hepatology, 2017.
  29. Meyers TJ, Chang SC, Chang PY, Morgenstern H, Tashkin DP, Rao JY, Cozen W, Mack TM, Zhang ZF. Case-control study of cumulative cigarette tar exposure and lung and upper aerodigestive tract cancers.. International journal of cancer, 2017.
  30. Yu W, Sharma S, Gimzewski JK, Rao J. Nanocytology as a potential biomarker for cancer.. Biomarkers in medicine, 2017.
  31. Yu W, Qin X, Jin Y, Li Y, Santiskulvong C, Vu V, Zeng G, Zhang Z, Chow M, Rao J. Tianshengyuan-1 (TSY-1) regulates cellular Telomerase activity by methylation of TERT promoter.. Oncotarget, 2017.
  32. Miles FL, Chang SC, Morgenstern H, Tashkin D, Rao JY, Cozen W, Mack T, Lu QY, Zhang ZF. Erratum to: Association of sugary beverages with survival among patients with cancers of the upper aerodigestive tract.. Cancer causes & control : CCC, 2016.
  33. Woo JS, Apple SK, Sullivan PS, Rao JY, Ostrzega N, Moatamed NA. Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience.. Diagnostic pathology, 2016.
  34. Miles FL, Chang SC, Morgenstern H, Tashkin D, Rao JY, Cozen W, Mack T, Lu QY, Zhang ZF. Association of sugary beverages with survival among patients with cancers of the upper aerodigestive tract.. Cancer causes & control : CCC, 2016.
  35. Miles FL, Chang SC, Morgenstern H, Tashkin D, Rao JY, Cozen W, Mack T, Lu QY, Zhang ZF. Associations of red and processed meat with survival among patients with cancers of the upper aerodigestive tract and lung.. Nutrition research (New York, N.Y.), 2016.
  36. Wu JX, Lam R, Levin M, Rao J, Sullivan PS, Yeh MW. Effect of malignancy rates on cost-effectiveness of routine gene expression classifier testing for indeterminate thyroid nodules.. Surgery, 2015.
  37. Yang SE, Sullivan PS, Zhang J, Govind R, Levin MR, Rao JY, Moatamed NA. Has Afirma gene expression classifier testing refined the indeterminate thyroid category in cytology?. Cancer cytopathology, 2015.
  38. Chan EH, Chen L, Rao JY, Yu F, Deng SX. Limbal Basal Cell Density Decreases in Limbal Stem Cell Deficiency.. American journal of ophthalmology, 2015.
  39. Miles FL, Rao JY, Eckhert C, Chang SC, Pantuck A, Zhang ZF. Associations of immunity-related single nucleotide polymorphisms with overall survival among prostate cancer patients.. International journal of clinical and experimental medicine, 2015.
  40. Kandukuri SR, Rao J. FIGO 2013 staging system for ovarian cancer: what is new in comparison to the 1988 staging system?. Current opinion in obstetrics & gynecology, 2015.
  41. Chang S, Smith E, Levin M, Rao JY, Moatamed NA. Comparative study of ProEx C immunocytochemistry and UroVysion fluorescent in-situ hybridization assays on urine cytology specimens.. CytoJournal, 2015.
  42. Seideman C, Canter D, Kim P, Cordon B, Weizer A, Oliva I, Rao J, Inman BA, Posch M, Herr H, Lotan Y. Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?. World journal of urology, 2014.
  43. Vergara-Lluri ME, Hu E, Rao JY, Levin M, Apple SK, Moatamed NA. Comparative evaluation of ProEx C and ImmunoCyt/uCyt assays in atypical urine cytology.. Archives of pathology & laboratory medicine, 2014.
  44. Zhao C, Li Z, Nayar R, Levi AW, Winkler BA, Moriarty AT, Barkan GA, Rao J, Miller F, Fan F, Zhou Z, Si Q, Fischer AH, Sturgis CD, Jing X, Marshall CB, Witt BL, Birdsong GG, Crothers BA. Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study.. Archives of pathology & laboratory medicine, 2014.
  45. Lu S, Qin X, Yuan S, Li Y, Wang L, Jin Y, Zeng G, Yen L, Hu J, Dang T, Song S, Hou Q, Rao J. Effect of Tianshengyuan-1 (TSY-1) on telomerase activity and hematopoietic recovery - in vitro, ex vivo, and in vivo studies.. International journal of clinical and experimental medicine, 2014.
  46. Liu B, Tahk S, Yee KM, Yang R, Yang Y, Mackie R, Hsu C, Chernishof V, O'Brien N, Jin Y, Fan G, Lane TF, Rao J, Slamon D, Shuai K. PIAS1 regulates breast tumorigenesis through selective epigenetic gene silencing.. PloS one, 2014.
  47. Moatamed NA, Vergara-Lluri ME, Lu D, Apple SK, Kerkoutian S, Rao JY. Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions.. Human pathology, 2013.
  48. Freedland SJ, Carducci M, Kroeger N, Partin A, Rao JY, Jin Y, Kerkoutian S, Wu H, Li Y, Creel P, Mundy K, Gurganus R, Fedor H, King SA, Zhang Y, Heber D, Pantuck AJ. A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy.. Cancer prevention research (Philadelphia, Pa.), 2013.
  49. Jeon C, Chang SC, Mu L, Zhao J, Rao JY, Lu QY, Zhang ZF. Genetic variants of peroxisome proliferator-activated receptor δ are associated with gastric cancer.. Digestive diseases and sciences, 2013.
  50. Mahoney ME, Gordon EJ, Rao JY, Jin Y, Hylton N, Love SM. Intraductal therapy of ductal carcinoma in situ: a presurgery study.. Clinical breast cancer, 2013.
  51. Moatamed NA, Rao JY, Alexanian S, Cobarrubias M, Levin M, Lu D, Apple SK. ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens.. Cancer cytopathology, 2013.
  52. Vora AA, Lai CK, Rao JY, Apple SK, Moatamed NA. Paraganglioma with unusual presentation in parotid gland: A diagnostic dilemma in fine needle aspiration.. CytoJournal, 2012.
  53. Lu QY, Jin Y, Mao JT, Zhang ZF, Heber D, Dubinett SM, Rao J. Green tea inhibits cycolooxygenase-2 in non-small cell lung cancer cells through the induction of Annexin-1.. Biochemical and biophysical research communications, 2012.
  54. Zhang L, Pang E, Loo RR, Rao J, Go VL, Loo JA, Lu QY. Concomitant inhibition of HSP90, its mitochondrial localized homologue TRAP1 and HSP27 by green tea in pancreatic cancer HPAF-II cells.. Proteomics, 2011.
  55. Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D. Lung cancer chemoprevention with celecoxib in former smokers.. Cancer prevention research (Philadelphia, Pa.), 2011.
  56. Xie C, Kim HJ, Haw JG, Kalbasi A, Gardner BK, Li G, Rao J, Chia D, Liong M, Punzalan RR, Marks LS, Pantuck AJ, de la Taille A, Wang G, Mukouyama H, Zeng G. A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases.. Journal of translational medicine, 2011.
  57. Cross SE, Jin YS, Lu QY, Rao J, Gimzewski JK. Green tea extract selectively targets nanomechanics of live metastatic cancer cells.. Nanotechnology, 2011.
  58. Wilson L, Cross S, Gimzewski J, Rao J. Nanocytology: a novel class of biomarkers for cancer management.. IDrugs : the investigational drugs journal, 2010.
  59. Oh SS, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, He N, Jiang Q, Kheifets L, Le A, Lee YC, Liu S, Lu ML, Mao JT, Morgenstern H, Mu LN, Pantuck A, Papp JC, Park SL, Rao JY, Reuter VE, Tashkin DP, Wang H, You NC, Yu SZ, Zhao JK, Belldegrun A, Zhang ZF. Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers.. International journal of cancer, 2010.
  60. Mao JT, Nie WX, Tsu IH, Jin YS, Rao JY, Lu QY, Zhang ZF, Go VL, Serio KJ. White tea extract induces apoptosis in non-small cell lung cancer cells: the role of peroxisome proliferator-activated receptor-{gamma} and 15-lipoxygenases.. Cancer prevention research (Philadelphia, Pa.), 2010.
  61. Park SL, Bastani D, Goldstein BY, Chang SC, Cozen W, Cai L, Cordon-Cardo C, Ding B, Greenland S, He N, Hussain SK, Jiang Q, Lee YC, Liu S, Lu ML, Mack TM, Mao JT, Morgenstern H, Mu LN, Oh SS, Pantuck A, Papp JC, Rao J, Reuter VE, Tashkin DP, Wang H, You NC, Yu SZ, Zhao JK, Zhang ZF. Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers.. Carcinogenesis, 2010.
  62. Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Garraway I, Wong SG, Belldegrun AS, Pantuck AJ. Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome.. The Journal of urology, 2010.
  63. Li HX, Li M, Li CL, Ma JH, Wang MR, Rao J, Pan QJ. ImmunoCyt and cytokeratin 20 immunocytochemistry as adjunct markers for urine cytologic detection of bladder cancer: a prospective study.. Analytical and quantitative cytology and histology, 2010.
  64. Nosov V, Park S, Rao J, Memarzadeh S. Non-Peutz-Jeghers syndrome associated ovarian sex cord tumor with annular tubules: a case report.. Fertility and sterility, 2009.
  65. Hussain SK, Mu LN, Cai L, Chang SC, Park SL, Oh SS, Wang Y, Goldstein BY, Ding BG, Jiang Q, Rao J, You NC, Yu SZ, Papp JC, Zhao JK, Wang H, Zhang ZF. Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009.
  66. Sheng JQ, Li SR, Wu ZT, Xia CH, Wu X, Chen J, Rao J. Transferrin dipstick as a potential novel test for colon cancer screening: a comparative study with immuno fecal occult blood test.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009.
  67. Sullivan PS, Nooraie F, Sanchez H, Hirschowitz S, Levin M, Rao PN, Rao J. Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma: a "split-sample" study.. Cancer, 2009.
  68. Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Kawaoka K, Wong SG, Belldegrun AS, Pantuck AJ. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.. Cancer, 2009.
  69. Klatte T, Said JW, de Martino M, Larochelle J, Shuch B, Rao JY, Thomas GV, Kabbinavar FF, Belldegrun AS, Pantuck AJ. Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification.. The Journal of urology, 2009.
  70. Lu QY, Yang Y, Jin YS, Zhang ZF, Heber D, Li FP, Dubinett SM, Sondej MA, Loo JA, Rao JY. Effects of green tea extract on lung cancer A549 cells: proteomic identification of proteins associated with cell migration.. Proteomics, 2009.
  71. Park SL, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, Hussain SK, Jiang Q, Liu S, Lu ML, Mao JT, Morgenstern H, Mu LN, Ng LJ, Pantuck A, Rao J, Reuter VE, Tashkin DP, You NC, Yu CQ, Yu SZ, Zhao JK, Belldegrun A, Zhang ZF. Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2008.
  72. Cross SE, Jin YS, Tondre J, Wong R, Rao J, Gimzewski JK. AFM-based analysis of human metastatic cancer cells.. Nanotechnology, 2008.
  73. Norris AJ, Sartippour MR, Lu M, Park T, Rao JY, Jackson MI, Fukuto JM, Brooks MN. Nitroxyl inhibits breast tumor growth and angiogenesis.. International journal of cancer, 2008.
  74. Karam A, Berek JS, Stenson A, Rao J, Dorigo O. HER-2/neu targeting for recurrent vulvar Paget's disease A case report and literature review.. Gynecologic oncology, 2008.
  75. Sartippour MR, Seeram NP, Rao JY, Moro A, Harris DM, Henning SM, Firouzi A, Rettig MB, Aronson WJ, Pantuck AJ, Heber D. Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo.. International journal of oncology, 2008.
  76. Shi R, Xie Q, Gang X, Lun J, Cheng L, Pantuck A, Rao J. Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China.. The Journal of urology, 2007.
  77. Cross SE, Jin YS, Rao J, Gimzewski JK. Nanomechanical analysis of cells from cancer patients.. Nature nanotechnology, 2007.
  78. Klatte T, Rao JY, Ribas A, Pantuck AJ. Metastatic melanoma to the kidney presenting with renal vein tumor thrombus.. Urology, 2007.
  79. Lu QY, Jin YS, Zhang ZF, Le AD, Heber D, Li FP, Dubinett SM, Rao JY. Green tea induces annexin-I expression in human lung adenocarcinoma A549 cells: involvement of annexin-I in actin remodeling.. Laboratory investigation; a journal of technical methods and pathology, 2007.
  80. Xiao GS, Jin YS, Lu QY, Zhang ZF, Belldegrun A, Figlin R, Pantuck A, Yen Y, Li F, Rao J. Annexin-I as a potential target for green tea extract induced actin remodeling.. International journal of cancer, 2007.
  81. Soung Sullivan P, Rao J, Cheng L, Cote RJ. Classical pathology versus molecular pathology in renal cell carcinoma.. Current urology reports, 2007.
  82. Zeng G, Aldridge ME, Tian X, Seiler D, Zhang X, Jin Y, Rao J, Li W, Chen D, Langford MP, Duggan C, Belldegrun AS, Dubinett SM. Dendritic cell surface calreticulin is a receptor for NY-ESO-1: direct interactions between tumor-associated antigen and the innate immune system.. Journal of immunology (Baltimore, Md. : 1950), 2006.
  83. Hung RJ, Zhang ZF, Rao JY, Pantuck A, Reuter VE, Heber D, Lu QY. Protective effects of plasma carotenoids on the risk of bladder cancer.. The Journal of urology, 2006.
  84. Zhang W, Yang YC, Zhang BN, Pan QJ, Hart SD, Duvall K, Zhang ZF, Rao JY. Biomarker analysis on breast ductal lavage cells in women with and without breast cancer.. International journal of cancer, 2006.
  85. Jin Y, Iwata KK, Belldegrun A, Figlin R, Pantuck A, Zhang ZF, Lieberman R, Rao J. Effect of an epidermal growth factor receptor tyrosine kinase inhibitor on actin remodeling in an in vitro bladder cancer carcinogenesis model.. Molecular cancer therapeutics, 2006.
  86. Sartippour MR, Pietras R, Marquez-Garban DC, Chen HW, Heber D, Henning SM, Sartippour G, Zhang L, Lu M, Weinberg O, Rao JY, Brooks MN. The combination of green tea and tamoxifen is effective against breast cancer.. Carcinogenesis, 2006.
  87. Zhang Q, Tang X, Lu Q, Zhang Z, Rao J, Le AD. Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.. Molecular cancer therapeutics, 2006.
  88. Cao W, Cai L, Rao JY, Pantuck A, Lu ML, Dalbagni G, Reuter V, Scher H, Cordon-Cardo C, Figlin RA, Belldegrun A, Zhang ZF. Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma.. Cancer, 2005.
  89. Chuang SC, Hashibe M, Yu GP, Le AD, Cao W, Hurwitz EL, Rao JY, Neugut AI, Zhang ZF. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.. Cancer letters, 2005.
  90. Lu M, Zhang L, Maul RS, Sartippour MR, Norris A, Whitelegge J, Rao JY, Brooks MN. The novel gene EG-1 stimulates cellular proliferation.. Cancer research, 2005.
  91. Wiley DJ, Huh J, Rao JY, Chang C, Goetz M, Poulter M, Masongsong E, Chang CI, Bernard HU. Methylation of human papillomavirus genomes in cells of anal epithelia of HIV-infected men.. Journal of acquired immune deficiency syndromes (1999), 2005.
  92. Wiriosuparto S, Krassilnik N, Bhuta S, Rao J, Firschowitz S. Solitary fibrous tumor: report of a case with an unusual presentation as a spindle cell parotid neoplasm.. Acta cytologica, 2005.
  93. Lu QY, Jin YS, Pantuck A, Zhang ZF, Heber D, Belldegrun A, Brooks M, Figlin R, Rao J. Green tea extract modulates actin remodeling via Rho activity in an in vitro multistep carcinogenic model.. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005.
  94. Sartippour MR, Seeram NP, Heber D, Hardy M, Norris A, Lu Q, Zhang L, Lu M, Rao JY, Brooks MN. Rabdosia rubescens inhibits breast cancer growth and angiogenesis.. International journal of oncology, 2005.
  95. Lu QY, Jin YS, Zhang Q, Zhang Z, Heber D, Go VL, Li FP, Rao JY. Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro.. Cancer letters, 2004.
  96. Rao J, Li N. Microfilament actin remodeling as a potential target for cancer drug development.. Current cancer drug targets, 2004.
  97. Zhang L, Maul RS, Rao J, Apple S, Seligson D, Sartippour M, Rubio R, Brooks MN. Expression pattern of the novel gene EG-1 in cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004.
  98. Mao GE, Reuter VE, Cordon-Cardo C, Dalbagni G, Scher HI, DeKernion JB, Zhang ZF, Rao J. Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2004.
  99. Sartippour MR, Rao JY, Apple S, Wu D, Henning S, Wang H, Elashoff R, Rubio R, Heber D, Brooks MN. A pilot clinical study of short-term isoflavone supplements in breast cancer patients.. Nutrition and cancer, 2004.
  100. Cheng L, Reiter RE, Jin Y, Sharon H, Wieder J, Lane TF, Rao J. Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens.. The Journal of urology, 2003.
  101. Espineda C, Seligson DB, James Ball W, Rao J, Palotie A, Horvath S, Huang Y, Shi T, Rajasekaran AK. Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays.. Cancer, 2003.
  102. Visapää H, Seligson D, Eeva M, Gaber F, Rao J, Belldegrun A, Palotie A. 8q24 amplification in transitional cell carcinoma of bladder.. Applied immunohistochemistry & molecular morphology : AIMM, 2003.
  103. Cao W, Hashibe M, Rao JY, Morgenstern H, Zhang ZF. Comparison of methods for DNA extraction from paraffin-embedded tissues and buccal cells.. Cancer detection and prevention, 2003.
  104. Zhang W, Wang L, Chang A, Jin Y, Rao J. Immunohistochemical analysis of cyclooxygenase-2 expression in premalignant and malignant esophageal glandular and squamous lesions in Cixian, China.. Cancer detection and prevention, 2003.
  105. Visapää H, Seligson D, Huang Y, Rao JY, Belldegrun A, Horvath S, Palotie A. Ki67, gelsolin and PTEN expression in sarcomatoid renal tumors.. Urological research, 2002.
  106. Rao J, Seligson D, Visapaa H, Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A. Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.. Cancer, 2002.
  107. Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J, Chang DD. Gene expression in epithelial ovarian carcinoma.. Oncogene, 2002.
  108. Rao J, Seligson D, Hemstreet GP. Protein expression analysis using quantitative fluorescence image analysis on tissue microarray slides.. BioTechniques, 2002.
  109. Rao J. Targeting actin remodeling profiles for the detection and management of urothelial cancers--a perspective for bladder cancer research.. Frontiers in bioscience : a journal and virtual library, 2002.
  110. Han KR, Pantuck AJ, Belldegrun AS, Rao JY. Tumor markers for the early detection of bladder cancer.. Frontiers in bioscience : a journal and virtual library, 2002.
  111. Rao JY, Apple SK, Jin Y, Lin S, Nieberg RK, Hirtschowitz SL. Comparative polymerase chain reaction analysis of c-myc amplification on archival breast fine-needle aspiration materials.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2000.